Bayer Healthcare Pharmaceuticals Inc.: Drug Recall

Recall #D-0236-2022 · 10/01/2021

Class II: Risk

Recall Details

Recall Number
D-0236-2022
Classification
Class II
Product Type
Drug
Recalling Firm
Bayer Healthcare Pharmaceuticals Inc.
Status
Terminated
Date Initiated
10/01/2021
Location
Whippany, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,817,468 cans

Reason for Recall

cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.

Product Description

LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3

Distribution Pattern

Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.